41236497,41255133,41255102,41235914,41251332,41270056,41259314,41248163[uid] - Search Results

1

The development of a pan-genotypic T cell vaccine against hepatitis C virus using heterologous prime-boost strategies.

Strain R, Edmans M, Montalvo Zurbia-Flores G, Frumento N, Brown A, Hutchings C, Board C, Knight C, Flyak AI, Bailey J, Lauer G, Cox A, Klenerman P, Barnes E. Strain R, et al. Hepatology. 2025 Nov 14. doi: 10.1097/HEP.0000000000001599. Online ahead of print. Hepatology. 2025. PMID: 41236497

2

Clinical and Immunological Impact of Occult Hepatitis B Virus Infection Among HIV-Infected Patients With and Without HCV Co-Infection in Iran: A Cross-Sectional Analysis.

Fazli P, Bakhtiari S, Jalilian FA, Teimoori A, Ansari N. Fazli P, et al. J Med Virol. 2025 Nov;97(11):e70715. doi: 10.1002/jmv.70715. J Med Virol. 2025. PMID: 41255133

3

Sofosbuvir/Velpatasvir/Voxilaprevir Versus Sofosbuvir/Velpatasvir Plus Ribavirin in Patients With Hepatitis C Virus Genotype 3b and Compensated Cirrhosis: A Multicentre Randomized Controlled Trial.

Huang R, Ji F, Jiang Y, Li S, Su M, Zhong Y, Zu H, Ding Y, Kong X, Shang J, Wei L, Rao H. Huang R, et al. J Med Virol. 2025 Nov;97(11):e70709. doi: 10.1002/jmv.70709. J Med Virol. 2025. PMID: 41255102 Clinical Trial.

4

Solute Carrier Gene Polymorphism (SLC29A1) in Relation to Treatment Outcome and Hematological Changes in Chronic Hepatitis C Patients Treated With Direct Acting Antivirals Plus Ribavirin.

Abdel-Samiee M, Aburaia G, Abdelsameea E, Fathy S, Elshaarawy O, Bedair HM. Abdel-Samiee M, et al. J Med Virol. 2025 Nov;97(11):e70692. doi: 10.1002/jmv.70692. J Med Virol. 2025. PMID: 41235914

5

Bridging the Gap: How Distance to Hospitals Limits HCV Treatment Initiation in France.

Marcellin F, di Beo V, Sogni P, Ramier C, Brouard C, Allier Y, Mourad A, Bureau-Stoltmann M, Deuffic-Burban S, Carrieri P, Rolland B, Bourliere M, Protopopescu C. Marcellin F, et al. J Viral Hepat. 2025 Dec;32(12):e70102. doi: 10.1111/jvh.70102. J Viral Hepat. 2025. PMID: 41251332 No abstract available.

6

Evaluation of a "one-stop shop" for integrated harm reduction and primary care for people who inject drugs.

Ibrahim N, Jones S, Rich K, Alvarez L, Price C, Kil N, Altice FL, Meyer JP. Ibrahim N, et al. PLoS One. 2025 Nov 21;20(11):e0337528. doi: 10.1371/journal.pone.0337528. eCollection 2025. PLoS One. 2025. PMID: 41270056 Free PMC article.

7

Scalp haircuts, keloids and blood-borne virus transmission risk in South Africa-The SHAKA study.

Khumalo N, Mankahla A, Korsman S, Gumedze F, Basera W, Ndyenga A, Mhlanti L, Setshedi M, Barnabas R, Spearman CW, Sonderup MW. Khumalo N, et al. PLoS One. 2025 Nov 19;20(11):e0336213. doi: 10.1371/journal.pone.0336213. eCollection 2025. PLoS One. 2025. PMID: 41259314 Free PMC article.

8

Barriers and facilitators to HIV and viral hepatitis testing in primary healthcare settings in the Kyrgyz Republic: A mixed-methods study using the COM-B Framework.

Sperle I, Lunchenkov N, Stepanovich-Falke A, Nurmatov ZS, Bekbolotov AA, Bolotbaeva A, Taalaibekov A, Abdrakhmanova Z, Aidarbekovna ZA, Brandl M, Kysil O, Bivol S, Bremer V, Gunsenheimer-Bartmeyer B, Dudareva S. Sperle I, et al. PLoS One. 2025 Nov 17;20(11):e0336257. doi: 10.1371/journal.pone.0336257. eCollection 2025. PLoS One. 2025. PMID: 41248163 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters